In a landmark decision, the Delhi High Court overturned an injunction against Natco, allowing them to produce a generic version of Novartis’s cancer drug. The Court held that Novartis’s patent on a specific salt form of the drug (ELT-O) lacked novelty due to its coverage in an earlier patent (IN’176).
Read more about Cancerous Battle: Novartis and NATCO clash over EltrombopagTag: Public Health
Intellectual Property, Accessibility and Public health
On the 30th of July 2020, the international organizations - WIPO, WTO and WHO jointly published a study report titled "Promoting access to medical technologies...
Read more about Intellectual Property, Accessibility and Public healthCoronavirus disease (COVID-19) advice for the public – World Health Organization (WHO)
BananaIP team is sharing the latest information provided by World Health Organization (WHO) on the COVID-19 outbreak, available on the WHO website. Most people who...
Read more about Coronavirus disease (COVID-19) advice for the public – World Health Organization (WHO)Extension of Waiver for Pharma Patents until 2033 A.D.
After intense negotiations between the United States and the Group of Least-Developed Countries, the World Trade Organization committee on intellectual property rights finally decided to...
Read more about Extension of Waiver for Pharma Patents until 2033 A.D.